메뉴 건너뛰기




Volumn 33, Issue 1, 2001, Pages 7-12

Plasma levels of vitamin E in Parkinson's disease

Author keywords

Antioxidant agents; Etiology; Free radicals; Neurodegenerative diseases; Oxidative stress; Parkinson's disease; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; CHOLINERGIC RECEPTOR BLOCKING AGENT; FREE RADICAL; LEVODOPA; REACTIVE OXYGEN METABOLITE;

EID: 0034924556     PISSN: 01674943     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-4943(01)00092-9     Document Type: Article
Times cited : (25)

References (21)
  • 2
    • 0024948366 scopus 로고
    • The endogenous toxin hypothesis of the etiology of Parkinson's disease and a pilot trial of high dose antioxidant in attempt to slow the progress of the illness
    • (1989) Ann. NY Acad. Sci. , vol.570 , pp. 186-196
    • Fahn, S.1
  • 3
    • 0026636491 scopus 로고
    • A pilot trial of high dose α-tocopherol and ascorbate in early Parkinson's disease
    • (1992) Ann. Neurol. , vol.32
    • Fahn, S.1
  • 4
    • 0000224448 scopus 로고
    • Unified Parkinson's disease rating scale
    • Fahn S., Marsden C.D., Calne D.B. (Eds.), Recent Developments in Parkinson's Disease, London: Macmillan
    • (1987) , pp. 153-163
    • Fahn, S.1    Elton, R.L.2
  • 12
    • 0022979978 scopus 로고
    • Interpretations of requirements for thiamin, riboflavin, niacin-tryptophan, and vitamin E plus comments on balance studies and vitamin B6
    • (1986) Am. J. Clin. Nutr. , vol.44 , pp. 973-985
    • Horwitt, M.K.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.